These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 8706776)
21. The reproducibility of quinine bioavailability. Paintaud G; Alván G; Ericsson O Br J Clin Pharmacol; 1993 Mar; 35(3):305-7. PubMed ID: 8471408 [TBL] [Abstract][Full Text] [Related]
22. Interactions among primaquine, malaria infection and other antimalarials in Thai subjects. Edwards G; McGrath CS; Ward SA; Supanaranond W; Pukrittayakamee S; Davis TM; White NJ Br J Clin Pharmacol; 1993 Feb; 35(2):193-8. PubMed ID: 8443039 [TBL] [Abstract][Full Text] [Related]
23. Absence of significant pharmacokinetic and pharmacodynamic interactions between artemether and quinoline antimalarials. Na-Bangchang K; Karbwang J; Ubalee R; Thanavibul A; Saenglertsilapachai S Eur J Drug Metab Pharmacokinet; 2000; 25(3-4):171-8. PubMed ID: 11420886 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of quinine and 3-hydroxyquinine in severe falciparum malaria with acute renal failure. Newton P; Keeratithakul D; Teja-Isavadharm P; Pukrittayakamee S; Kyle D; White N Trans R Soc Trop Med Hyg; 1999; 93(1):69-72. PubMed ID: 10492795 [TBL] [Abstract][Full Text] [Related]
25. Regional differences in quinine absorption from the undisturbed human colon assessed using a timed release delivery system. Hebden JM; Wilson CG; Spiller RC; Gilchrist PJ; Blackshaw E; Frier ME; Perkins AC Pharm Res; 1999 Jul; 16(7):1087-92. PubMed ID: 10450935 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic Interactions Between Quinine and Lopinavir/Ritonavir in Healthy Thai Adults. Rattanapunya S; Cressey TR; Rueangweerayut R; Tawon Y; Kongjam P; Na-Bangchang K Am J Trop Med Hyg; 2015 Dec; 93(6):1383-90. PubMed ID: 26416104 [TBL] [Abstract][Full Text] [Related]
27. Nanoencapsulation increases quinine antimalarial efficacy against Plasmodium berghei in vivo. Haas SE; Bettoni CC; de Oliveira LK; Guterres SS; Dalla Costa T Int J Antimicrob Agents; 2009 Aug; 34(2):156-61. PubMed ID: 19369041 [TBL] [Abstract][Full Text] [Related]
28. Intrarectal pharmacokinetics of two formulations of quinine in children with falciparum malaria. Barennes H; Sterlingot H; Nagot N; Meda H; Kaboré M; Sanou M; Nacro B; Bourée P; Pussard E Eur J Clin Pharmacol; 2003 Feb; 58(10):649-52. PubMed ID: 12610739 [TBL] [Abstract][Full Text] [Related]
29. Quinine disposition in globally malnourished children with cerebral malaria. Pussard E; Barennes H; Daouda H; Clavier F; Sani AM; Osse M; Granic G; Verdier F Clin Pharmacol Ther; 1999 May; 65(5):500-10. PubMed ID: 10340915 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications. Krishna S; White NJ Clin Pharmacokinet; 1996 Apr; 30(4):263-99. PubMed ID: 8983859 [TBL] [Abstract][Full Text] [Related]
31. Disposition of quinine in plasma, red blood cells and saliva after oral and intravenous administration to healthy adult Africans. Salako LA; Sowunmi A Eur J Clin Pharmacol; 1992; 42(2):171-4. PubMed ID: 1618248 [TBL] [Abstract][Full Text] [Related]
32. Comparison of the pharmacokinetics of lamotrigine in patients with chronic renal failure and healthy volunteers. Wootton R; Soul-Lawton J; Rolan PE; Sheung CT; Cooper JD; Posner J Br J Clin Pharmacol; 1997 Jan; 43(1):23-7. PubMed ID: 9056048 [TBL] [Abstract][Full Text] [Related]
33. Taste-masked quinine sulphate pellets: bio-availability in adults and steady-state plasma concentrations in children with uncomplicated Plasmodium falciparum malaria. Kayumba PC; Twagirumukiza M; Huyghebaert N; Ntawukuliryayo JD; van Bortel L; Vervaet C; Remon JP Ann Trop Paediatr; 2008 Jun; 28(2):103-9. PubMed ID: 18510819 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of mefloquine when given as a single and two divided-dose regimens. Na-Bangchang K; Molunto P; Banmairuroi V; Thanavibul A; Karbwang J Int J Clin Pharmacol Res; 1995; 15(5-6):215-20. PubMed ID: 8835620 [TBL] [Abstract][Full Text] [Related]
35. The pharmacokinetics of quinine in patients with hepatitis. Karbwang J; Thanavibul A; Molunto P; Na Bangchang K Br J Clin Pharmacol; 1993 Apr; 35(4):444-6. PubMed ID: 8485027 [TBL] [Abstract][Full Text] [Related]
36. Metabolism and elimination of quinine in healthy volunteers. Mirghani RA; Hellgren U; Bertilsson L; Gustafsson LL; Ericsson O Eur J Clin Pharmacol; 2003 Sep; 59(5-6):423-7. PubMed ID: 12920491 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of bendazac-lysine and 5-hydroxybendazac in patients with renal insufficiency. Rovei V; Campistron G; Dueymes JM; Ego D; Conte JJ; Houin G Eur J Clin Pharmacol; 1987; 33(3):303-10. PubMed ID: 3691618 [TBL] [Abstract][Full Text] [Related]
38. Quinine as a potential tracer for medication adherence: A pharmacokinetic and pharmacodynamic assessment of quinine alone and in combination with oxycodone in humans. Babalonis S; Hampson AJ; Lofwall MR; Nuzzo PA; Walsh SL J Clin Pharmacol; 2015 Dec; 55(12):1332-43. PubMed ID: 26032168 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of ranitidine in patients with chronic renal failure. McFadyen ML; Folb PI; Miller R; Keeton GR; Marks IN Eur J Clin Pharmacol; 1983; 25(3):347-51. PubMed ID: 6313378 [TBL] [Abstract][Full Text] [Related]
40. Disposition of oral quinine in African patients suffering from acute uncomplicated falciparum malaria. Sowunmi A East Afr Med J; 1996 Aug; 73(8):519-23. PubMed ID: 8898467 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]